This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Academia Sinica. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yi-ling Lin: Innovator in COVID-19 Antibody Research
Introduction
Yi-ling Lin is a prominent inventor based in New Taipei City, Taiwan. He has made significant contributions to the field of medical research, particularly in the development of neutralizing antibodies for the prevention and treatment of COVID-19. His innovative work has garnered attention and recognition in the scientific community.
Latest Patents
Yi-ling Lin holds a patent titled "Potent Neutralizing Antibodies for Prevention and Treatment of COVID-19." This patent represents a crucial advancement in the fight against the pandemic, showcasing his dedication to improving public health through scientific innovation. He has 1 patent to his name.
Career Highlights
Lin is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His role at Academia Sinica allows him to collaborate with leading scientists and contribute to groundbreaking research in the field of immunology and infectious diseases.
Collaborations
Throughout his career, Yi-ling Lin has worked alongside esteemed colleagues, including Han-Chung Wu and Mi-Hua Tao. These collaborations have further enhanced his research capabilities and have led to significant advancements in the understanding of neutralizing antibodies.
Conclusion
Yi-ling Lin's contributions to the field of COVID-19 research exemplify the impact of innovative thinking in addressing global health challenges. His work continues to inspire future research and development in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile